tiprankstipranks
Trending News
More News >
Xylo Technologies Ltd (XYLO)
NASDAQ:XYLO

Xylo Technologies Ltd (XYLO) AI Stock Analysis

Compare
271 Followers

Top Page

XY

Xylo Technologies Ltd

(NASDAQ:XYLO)

Rating:48Neutral
Price Target:
$5.00
▼(-0.60%Downside)
Xylo Technologies Ltd's overall stock score is primarily impacted by its ongoing financial struggles, including negative cash flows and profitability issues. Technical analysis provides no strong signals, and the valuation is concerning due to a negative P/E ratio. The lack of earnings call data and corporate events means these factors do not influence the score.

Xylo Technologies Ltd (XYLO) vs. SPDR S&P 500 ETF (SPY)

Xylo Technologies Ltd Business Overview & Revenue Model

Company DescriptionXylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
How the Company Makes MoneyXylo Technologies Ltd generates revenue through a diversified portfolio of technology-driven services and products. The company's primary revenue streams include subscription-based software-as-a-service (SaaS) offerings, customized enterprise solutions, and cloud computing services. Additionally, XYLO earns significant income from consulting and implementation services, helping businesses integrate and optimize their digital infrastructures. Strategic partnerships with leading technology firms enhance XYLO's market reach and product offerings, while ongoing investments in research and development ensure a steady pipeline of innovative solutions that meet evolving customer needs. The company also capitalizes on data analytics and cybersecurity services, which are increasingly in demand as organizations prioritize data-driven decision-making and robust security measures.

Xylo Technologies Ltd Financial Statement Overview

Summary
Xylo Technologies Ltd faces significant financial challenges, characterized by declining revenues, persistent operational losses, and liquidity issues. Despite a positive equity ratio, high leverage and negative cash flows present ongoing risks.
Income Statement
45
Neutral
Xylo Technologies Ltd has faced significant challenges in maintaining revenue growth and profitability. The company experienced a notable decline in revenue from 2023 to 2024, with a negative revenue growth rate, and continues to report negative EBIT and net income margins. Despite a consistent gross profit margin, the inability to convert this into positive net income indicates ongoing operational inefficiencies.
Balance Sheet
55
Neutral
The company's balance sheet shows a mixed picture. A positive equity ratio reflects a solid capital structure, but the high debt-to-equity ratio indicates potential leverage risks. The declining equity and assets over the years highlight a need for strategic financial management to stabilize the company's financial position.
Cash Flow
50
Neutral
Xylo Technologies Ltd has struggled with negative operating and free cash flows, reflecting ongoing liquidity challenges. The company's cash flow from operations remains negative, accentuating the need for improved cash management. However, the reduction in net debt is a positive indicator, suggesting some progress in managing financial obligations.
Breakdown
TTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income StatementTotal Revenue
57.64M29.86M91.72M91.86M10.12M531.00K
Gross Profit
7.80M6.68M11.84M14.45M4.80M-503.00K
EBIT
-21.59M-8.02M-23.32M-8.58M-8.20M-7.46M
EBITDA
-5.20M-7.51M-12.19M-5.38M6.99M-7.30M
Net Income Common Stockholders
-15.99M-6.03M-16.02M-9.81M6.79M-4.33M
Balance SheetCash, Cash Equivalents and Short-Term Investments
9.51M14.67M12.54M25.23M27.34M22.36M
Total Assets
39.29M37.55M63.90M97.65M59.73M32.34M
Total Debt
6.49M6.86M9.79M10.13M1.62M107.00K
Net Debt
-185.00K-1.89M429.00K-10.12M-22.41M-22.26M
Total Liabilities
23.37M19.96M31.46M42.96M8.30M6.14M
Stockholders Equity
15.19M17.98M23.58M39.14M49.19M22.96M
Cash FlowFree Cash Flow
-4.15M-1.84M-7.99M-5.73M-10.39M-6.47M
Operating Cash Flow
-4.11M-1.82M-6.25M-5.66M-5.25M-6.14M
Investing Cash Flow
2.73M2.38M-4.06M-4.48M-12.21M-1.60M
Financing Cash Flow
-4.27M-998.00K-524.00K5.41M18.92M22.95M

Xylo Technologies Ltd Technical Analysis

Technical Analysis Sentiment
Positive
Last Price5.03
Price Trends
50DMA
5.11
Negative
100DMA
4.90
Positive
200DMA
4.25
Positive
Market Momentum
MACD
-0.04
Positive
RSI
49.23
Neutral
STOCH
44.86
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For XYLO, the sentiment is Positive. The current price of 5.03 is below the 20-day moving average (MA) of 5.06, below the 50-day MA of 5.11, and above the 200-day MA of 4.25, indicating a neutral trend. The MACD of -0.04 indicates Positive momentum. The RSI at 49.23 is Neutral, neither overbought nor oversold. The STOCH value of 44.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for XYLO.

Xylo Technologies Ltd Risk Analysis

Xylo Technologies Ltd disclosed 79 risk factors in its most recent earnings report. Xylo Technologies Ltd reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Xylo Technologies Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$4.17M-163.47%-100.00%78.91%
54
Neutral
$5.34B3.36-45.10%3.39%16.81%-0.03%
48
Neutral
$3.94M-28.99%-67.77%66.19%
45
Neutral
$1.34M-440.77%-1.21%93.72%
43
Neutral
$4.61M-496.27%-16.79%-3.69%
42
Neutral
$8.58M-155.20%9.90%94.56%
37
Underperform
$6.85M-120.16%-7.74%93.25%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
XYLO
Xylo Technologies Ltd
5.03
0.49
10.79%
NUWE
Nuwellis
0.27
-7.36
-96.46%
SINT
Sintx Technologies
3.34
-2.08
-38.38%
RSLS
ReShape Lifesciences
2.67
-270.51
-99.02%
VERO
Venus Concept
2.43
-7.17
-74.69%
HSCS
Heart Test Laboratories, Inc.
3.72
-1.43
-27.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.